[Federal Register Volume 67, Number 187 (Thursday, September 26, 2002)]
[Notices]
[Page 60688]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-24561]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Endocrinologic and Metabolic Drugs Advisory Committee; Amendment 
of Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
amendment to the notice of meeting of the Endocrinologic and Metabolic 
Drugs Advisory Committee. This meeting was announced in the Federal 
Register of August 1, 2002 (67 FR 49945). The amendment is being made 
to reflect a change in the Agenda portion of the document. The meeting 
was originally scheduled for September 25, 26, and 27, 2002. However, 
due to administrative complications, the discussions on September 26 
and 27, 2002, will be postponed until a later date. There are no other 
changes.

FOR FURTHER INFORMATION CONTACT: Kathleen Reedy, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or 
e-mail: [email protected], or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
12536, for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 1, 2002, 
FDA announced that a meeting of the Endocrinologic and Metabolic Drugs 
Advisory Committee would be held on September 25, 26, and 27, 2002. On 
page 49945, in the first column, the Agenda portion of the meeting is 
amended to read as follows:
    Agenda: On September 25, 2002, the committee will discuss 
appropriate designs for clinical trials of new osteoporosis treatments.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: September 23, 2002.
Linda Arey Skladany,
Senior Associate Commissioner for External Relations.
[FR Doc. 02-24561 Filed 9-23-02; 5:02 pm]
BILLING CODE 4160-01-S